Review Article Platelet to lymphocyte ratio as a prognostic marker for hepatocellular carcinoma

The neutrophil- lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), platelet-lymphocyte ratio (PLR), and mean platelet volume (MPV) can be used as factors to determine

Predictive value of pre transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation WORLD JOURNAL OF SURGICAL ONCOLOGY Xia et al

White blood cell (WBC) count, absolute neutrophil count, neutrophil percent, absolute lymphocyte count, lymphocyte percent, and NLR did not significantly differ before

efficacy evaluation of total lymphocyte count (TLC), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in advanced non–small cell lung cancer

Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease- free survival in patients with surgically treated esophageal squamous cell carcinoma. Arigami

Purpose: To compare the strength of the relationship between the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio(PLR) results of patients with or

Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have been investigated as potential markers in a number of cancers ranging from breast to GI

Although elevated neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been reported to be inverse prognostic predictors of survival in patients